ATE298567T1 - Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung - Google Patents
Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellungInfo
- Publication number
- ATE298567T1 ATE298567T1 AT01500053T AT01500053T ATE298567T1 AT E298567 T1 ATE298567 T1 AT E298567T1 AT 01500053 T AT01500053 T AT 01500053T AT 01500053 T AT01500053 T AT 01500053T AT E298567 T1 ATE298567 T1 AT E298567T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical composition
- ibuprofen
- production
- composition containing
- mixing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200000522A ES2171110B1 (es) | 2000-03-03 | 2000-03-03 | Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE298567T1 true ATE298567T1 (de) | 2005-07-15 |
Family
ID=8492565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01500053T ATE298567T1 (de) | 2000-03-03 | 2001-03-01 | Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1129709B1 (de) |
| AT (1) | ATE298567T1 (de) |
| CZ (1) | CZ301553B6 (de) |
| DE (1) | DE60111657T2 (de) |
| DK (1) | DK1129709T3 (de) |
| ES (1) | ES2171110B1 (de) |
| PT (1) | PT1129709E (de) |
| SK (1) | SK285338B6 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
| EP1942877A4 (de) * | 2005-11-02 | 2011-09-14 | Teikoku Pharma Usa Inc | Organoleptisch annehmbare orale dosierformen von ibuprofen, herstellungsverfahren und anwendung |
| EP1840188B1 (de) | 2006-03-31 | 2011-09-07 | Sony Deutschland GmbH | Zusammensetzung mit mindestens einer Art von Flüssigkristall |
| ES2303468B1 (es) * | 2007-01-22 | 2009-06-08 | Masterfarm, S.L | "una composicion farmaceutica pulverulenta que comprende ibuprofeno". |
| EP1974751A1 (de) * | 2007-03-26 | 2008-10-01 | The Jordanian Pharmaceutical Manufacturing Co. | Formulierungen für nichtsteroidale entzündungshemmende Arzneimittel |
| FR2914187B1 (fr) * | 2007-03-28 | 2011-01-21 | Pf Medicament | Complexes d'ibuprofene, de cyclodextrines et d'agents ternaires, et leurs utilisations en pharmaceutique. |
| DK2253329T3 (en) | 2009-04-27 | 2017-01-16 | Laboratorio De Aplicaciones Farm S A | Oral ibuprofen lysinate suspension. |
| TW201038296A (en) * | 2009-04-27 | 2010-11-01 | Aplicaciones Farmacodinamicas S A Lab De | Ibuprofen lysinate oral suspension |
| WO2014194872A1 (en) | 2013-06-04 | 2014-12-11 | Zentiva, K.S. | Taste masking of water soluble drugs using poloxamers |
| WO2024246565A2 (en) | 2023-06-02 | 2024-12-05 | Ioulia Tseti | Pharmaceutical composition comprising ibuprofen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8813682D0 (en) * | 1988-06-09 | 1988-07-13 | Reckitt & Colmann Prod Ltd | Pharmaceutical compositions |
| IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
| DE4038314A1 (de) * | 1990-11-30 | 1992-06-04 | Puetter Medice Chem Pharm | Komplexe des aktiven enantiomers des ibuprofens mit cyclodextrin |
| GB9207990D0 (en) * | 1992-04-10 | 1992-05-27 | Smithkline Beecham Plc | Pharmaceutical composition |
| GB9316580D0 (en) * | 1993-08-10 | 1993-09-29 | Smithkline Beecham Plc | Pharmaceutical composition |
| ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
-
2000
- 2000-03-03 ES ES200000522A patent/ES2171110B1/es not_active Expired - Fee Related
-
2001
- 2001-02-26 CZ CZ20010714A patent/CZ301553B6/cs not_active IP Right Cessation
- 2001-03-01 DE DE60111657T patent/DE60111657T2/de not_active Expired - Lifetime
- 2001-03-01 DK DK01500053T patent/DK1129709T3/da active
- 2001-03-01 EP EP01500053A patent/EP1129709B1/de not_active Expired - Lifetime
- 2001-03-01 PT PT01500053T patent/PT1129709E/pt unknown
- 2001-03-01 SK SK293-2001A patent/SK285338B6/sk not_active IP Right Cessation
- 2001-03-01 AT AT01500053T patent/ATE298567T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1129709A3 (de) | 2001-11-14 |
| SK2932001A3 (en) | 2001-12-03 |
| DK1129709T3 (da) | 2005-10-24 |
| CZ301553B6 (cs) | 2010-04-14 |
| DE60111657D1 (de) | 2005-08-04 |
| DE60111657T2 (de) | 2006-05-04 |
| SK285338B6 (sk) | 2006-11-03 |
| ES2171110B1 (es) | 2003-06-16 |
| EP1129709A2 (de) | 2001-09-05 |
| CZ2001714A3 (cs) | 2001-10-17 |
| ES2171110A1 (es) | 2002-08-16 |
| EP1129709B1 (de) | 2005-06-29 |
| PT1129709E (pt) | 2005-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001279631A1 (en) | Self-emulsifying active substance formulation and use of this formulation | |
| ES2126536A1 (es) | "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion. | |
| PT100234A (pt) | Novos esteres de alcoois aminados biciclicos e triciclicos, processo para a sua preparacao | |
| IL157963A0 (en) | Hsa-free formulations of interferon-beta | |
| ES2189803T3 (es) | Procedimiento. | |
| DK1064935T4 (da) | Fast lægemiddelsammensætning med kontrolleret frisætning opnået ved termo-formning | |
| ATE493133T1 (de) | Antibiotische/analgetische formulierung und verfahren zur herstellung dieser formulierung | |
| EA200600479A1 (ru) | Фармацевтический состав, включающий соединения лантана | |
| ATE359777T1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| ATE298567T1 (de) | Pharmazeutische zusammensetzung enthaltend ibuprofen und ein verfahren zur deren herstellung | |
| BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
| FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
| ATE424192T1 (de) | Stabile pharmazeutische zubereitungen mit 2-aza- bicyclo 3.3.0 -octan-3-carboxylsäure-derivaten | |
| DE69924304D1 (de) | N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin | |
| NO303715B1 (no) | Stabilt, vandig apparat | |
| HUT60245A (en) | Insecticidal compositions comprising 2-aryl-1-(alkoxymethyl)-4-halogen-5-(trifluoromethyl)-pyrrole derivatives as active ingredient and process for producing the active ingredient | |
| IL163608A (en) | Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders | |
| WO2003028624A3 (en) | Levothyroxine compositions and methods | |
| JPS5781409A (en) | External plaster | |
| ATE269352T1 (de) | 4-benzylaminochinoline konjugate mit gallensaeure und ihre heteroanalogen, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und deren anwendung | |
| ATE301452T1 (de) | Verfahren zur herstellung einer flüssigen dosierungseinheit und kit | |
| AU2002356685A1 (en) | Water-soluble non-effervescent pharmaceutical compositions comprising non-steroidal anti-inflammatory drugs | |
| AU2369801A (en) | Pharmaceutical composition for transdermally administering hormones with an additive that enhances permeation | |
| DE69108976D1 (de) | Neue Polycarbophil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung. | |
| ITMI20020872A1 (it) | Derivati dell'iperforina loro uso e formulazioni che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |